FdaApplication
BLA 761375
Identifiers
- fda_app_no: BLA761375
Properties
| Property | Value |
|---|---|
| applicant_name | Eisai, Incorporated |
| application_type | BLA |
| approval_date | 2025-08-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEQEMBI IQLIK | LECANEMAB-IRMB | 360MG/1.8ML(200MG/ML) | INJECTABLE;SUBCUTANEOUS |
| LEQEMBI IQLIK | — | 250MG/1.25ML (200MG/ML) | Injection |
| LEQEMBI IQLIK | — | 360MG/1.8ML (200MG/ML) | Injection |
3 products